November 16, 2026 — This week's device news points to one direction: health monitoring is moving out of the hospital and onto the body and the phone, with more projects focused on early warning rather than recording after the fact.
MIT Team Wins ARPA-H Funding for Early-Detection Wearable Patch
An MIT-led team will receive up to USD 38 million over four years from the U.S. Advanced Research Projects Agency for Health (ARPA-H) to develop a noninvasive wearable patch that continuously monitors biomarkers of heart disease and sepsis. The project, called PYTHIA (Predictive Platform for Physiological and Therapeutic Health Intervention and Adaptive Management), is aimed at catching deterioration earlier than current spot-check measurements allow.
Voice Analysis Passes Pivotal Heart Failure Study
Cordio Medical reported results from the DETECT-HF pivotal validation study of its HearO system, which uses smartphone-based voice and speech analysis for remote heart failure monitoring. The findings were presented as Late-Breaking Science at the American Heart Association meeting. The approach sidesteps extra hardware: patients record their voice through a phone, and the software looks for changes associated with worsening heart failure.
Cancer-Cardiac Wearable Advances in FDA Innovation Program
Skribe Medical said its Aurora System wearable cardiac patch has progressed in clinical development after selection for the FDA's READI-Home Innovation Challenge. The system targets heart monitoring for cancer patients, who face elevated cardiovascular risk during treatment.
Market: Clinical Wearable Monitoring on a 14.8% CAGR
The global clinical wearable monitoring devices market was valued at USD 22.0 billion in 2025 and is projected to grow from USD 24.8 billion in 2026 to USD 65.2 billion by 2033, a 14.8% CAGR, with remote patient monitoring as the main driver, according to a GlobeNewswire industry report.
What it means
The common element is continuous, low-burden data collection — a patch on the chest, a voice call on the phone — followed by an algorithm that flags patients who need a clinician's attention. For device suppliers, this keeps demand steady for sensing components that feed these systems: pulse oximetry, ECG, blood pressure and temperature modules, plus patient-monitoring accessories.
SaferLife Products Co., Ltd. supplies pulse oximeters, patient monitors and vital-signs accessories to distributors worldwide.

